Madeleine Duvic

1979–2025 年に発表

166
論文数
32,033
被引用数
103
h 指数
163
i10 指数

被引用数

Madeleine Duvic の年別被引用数1981 年: 被引用 1 件1982 年: 被引用 2 件1983 年: 被引用 1 件1984 年: 被引用 1 件1985 年: 被引用 3 件1986 年: 被引用 3 件1987 年: 被引用 3 件1988 年: 被引用 5 件1989 年: 被引用 21 件1990 年: 被引用 17 件1991 年: 被引用 15 件1992 年: 被引用 26 件1993 年: 被引用 25 件1994 年: 被引用 25 件1995 年: 被引用 23 件1996 年: 被引用 33 件1997 年: 被引用 43 件1998 年: 被引用 41 件1999 年: 被引用 60 件2000 年: 被引用 62 件2001 年: 被引用 63 件2002 年: 被引用 98 件2003 年: 被引用 111 件2004 年: 被引用 107 件2005 年: 被引用 112 件2006 年: 被引用 142 件2007 年: 被引用 198 件2008 年: 被引用 176 件2009 年: 被引用 211 件2010 年: 被引用 229 件2011 年: 被引用 221 件2012 年: 被引用 222 件2013 年: 被引用 207 件2014 年: 被引用 224 件2015 年: 被引用 232 件2016 年: 被引用 181 件2017 年: 被引用 272 件2018 年: 被引用 207 件2019 年: 被引用 797 件2020 年: 被引用 906 件2021 年: 被引用 893 件2022 年: 被引用 557 件2023 年: 被引用 465 件2024 年: 被引用 594 件2025 年: 被引用 280 件2026 年: 被引用 5 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,483 件、この内訳の 30.9%ドイツ: 引用元論文 519 件、この内訳の 6.5%中国: 引用元論文 516 件、この内訳の 6.4%イギリス: 引用元論文 509 件、この内訳の 6.3%イタリア: 引用元論文 412 件、この内訳の 5.1%フランス: 引用元論文 359 件、この内訳の 4.5%日本: 引用元論文 251 件、この内訳の 3.1%カナダ: 引用元論文 241 件、この内訳の 3%スペイン: 引用元論文 224 件、この内訳の 2.8%オーストラリア: 引用元論文 215 件、この内訳の 2.7%スイス: 引用元論文 196 件、この内訳の 2.5%オランダ: 引用元論文 183 件、この内訳の 2.3%
0%30.9%その他 23.9%

分野

  • Medicine61.1%
  • Biochemistry, Genetics and Molecular Biology27.2%
  • Immunology and Microbiology8.9%
  • Pharmacology, Toxicology and Pharmaceutics0.5%
  • Engineering0.5%
  • Computer Science0.3%
  • その他1.5%

トピック

  • Cutaneous lymphoproliferative disorders research7%
  • Lymphoma Diagnosis and Treatment5.3%
  • Histone Deacetylase Inhibitors Research3.9%
  • Hair Growth and Disorders3.2%
  • CAR-T cell therapy research2.6%
  • Dermatology and Skin Diseases2.3%
  • その他75.7%

共著者

全論文

検索で開く
  1. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Karen M. Dwyer, Junji Moriya, Mollie Leoni, Jeffrey S. Humphrey, Stacie Hudgens, Dmitri O. Grebennik, Kensei Tobinai, Madeleine Duvic, Sunil Abhyankar, Oleg E. Akilov, Önder Alpdoğan, M. Beylot‐Barry, Erin Boh, Dolores Caballero, Richard Cowan, Brigitte Dréno, Reinhard Dummer, Timothy S. Fenske, Francine Foss, Noriko Fukuhara, Pratyush Giri, Koji Habe, Toshihisa Hamada, Kiyohiko Hatake, Shinsuke Iida, Osamu Ishikawa, Lars Iversen, Eiji Kiyohara, Hiroshi Koga, Neil J. Korman, Bryone J. Kuss, Zanetta S. Lamar, Frederick Lansigan, Mary Jo Lechowicz, Adam Lerner, Nina Magnolo, Lawrence A. Mark, Tomomitsu Miyagaki, Javier Muñoz, Jan P. Nicolay, Kaoru Nishiwaki, Hiroyuki Okamoto, Mikio Ohtsuka, Theresa Pacheco, Christiane Querfeld, Ronald Peter Rapini, Shigetoshi Sano, Maiko Tanaka, Michael D. Tharp, Jiro Uehara, Hidefumi Wada, Jillian Wells, Ryan A. Wilcox, Basem M. William, Kentaro Yonekura - The Lancet Oncology 2018 被引用: 645

  2. Alopecia areata investigational assessment guidelines–Part II

    著者: , , , , , , , , , , , , , - Journal of the American Academy of Dermatology 2004 被引用: 786

  3. Cobomarsen, an oligonucleotide inhibitor of miR‐155, co‐ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T‐cell lymphoma

    著者: , , , , , , - British Journal of Haematology 2018 被引用: 315

  4. Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm

    著者: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2019 被引用: 417

  5. Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Meredith Little, Sean Whittaker, Madeleine Duvic, Judith Trotman, David Joske, H. Miles Prince, Kerry Taylor, Ian D. Lewis, Constanze Jonak, Franz Trautinger, Oliver Bechter, Pascal Wolter, Dominique Bron, Vladmir Cláudio Cordeiro de Lima, José Antônio Sanches, Richard Klasa, M. Bagot, M. Beylot‐Barry, Stéphane Dalle, M. D’Incan, Brigitte Dréno, Florent Grange, Jan P. Nicolay, Rudolf Stadler, Michael Weichenthal, Marion Wobser, Chalid Assaf, Carmen Loquai, Pietro Quaglino, Michele Spina, Pier Luigi Zinzani, Alberto Bosi, Pier Paolo Fattori, Aleksandra Grzanka, Jan Walewski, Andrés López‐Hernandez, Pablo L. Ortiz‐Romero, José J. Rifón Roca, Silvana Novelli Canales, Reinhard Dummer, Tim Illidge, Rod Johnson, Sean Whittaker, Stephen Morris, Pam McKay, Julia Scarisbrick, Madeleine Duvic, Tatyana Feldman, Oleg E. Akilov, Larisa J. Geskin, Steve Horwitz, Youn H. Kim, Barbara Pro, Timothy M. Kuzel, Adam Lerner, Herbert Eradat, Lubomir Sokol, David C. Fisher, S. Morgan Hughey - The Lancet 2017 被引用: 580

  6. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity

    著者: , , , , , , , , , , , , , , , - Nature 2010 被引用: 828

  7. Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)

    著者: , , , , , , , , , , , , , , , , , , , , - Blood 2007 被引用: 1,416

  8. Guidelines of care for the management of primary cutaneous melanoma

    著者: , , , , , , , , , , , , , , - Journal of the American Academy of Dermatology 2011 被引用: 616

  9. Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jasmine M. Zain, Robert Knobler, Rudolf Stadler, M. Bagot, Julia Scarisbrick - Blood 2021 被引用: 171

  10. Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma

    著者: , , , , , , , , , , - Journal of Clinical Oncology 2007 被引用: 1,048

  11. Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)

    著者: , , , , , , , , , , - Blood 2006 被引用: 1,137

  12. Discovery and clinical introduction of first-in-class imipridone ONC201

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark N. Stein, Wafik S. El‐Deiry - Oncotarget 2016 被引用: 166

  13. Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter Heald, Steven T. Rosen, Lorenzo Cerroni, Brigette Dréno, Eric C. Vonderheid - Journal of Clinical Oncology 2011 被引用: 658

  14. Diverse types of dermatologic toxicities from immune checkpoint blockade therapy

    著者: , , , , , , , , , , , - Journal of Cutaneous Pathology 2016 被引用: 228

  15. Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma

    著者: , , , , , , , , , , , , - Journal of Clinical Oncology 2010 被引用: 661

  16. Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cristina Muniesa, Emilio Berti, Francesco Onida, Laura Corti, Emilia Hodak, Iris Amitay‐Laish, Pablo L. Ortiz‐Romero, José Luis Rodríguez‐­Peralto, Robert Knobler, Stefanie Porkert, Wolfgang Bauer, Nicola Pimpinelli, Vieri Grandi, Richard Cowan, Alain H. Rook, Ellen Kim, Alessandro Pileri, Annalisa Patrizi, Ramón M. Pujol, Henry K. Wong, Kelly Tyler, René Stranzenbach, Christiane Querfeld, Paolo Fava, Milena Maule, Rein Willemze, Felicity Evison, Stephen Morris, Robert Twigger, Rakhshandra Talpur, Jinah Kim, G. Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, Madeleine Duvic, Sean Whittaker, Youn H. Kim - Journal of Clinical Oncology 2015 被引用: 421

  17. Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician’s choice in cutaneous T-cell lymphoma: final data

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Blood Advances 2021 被引用: 114

  18. Response to Brentuximab Vedotin by CD30 Expression in Non-Hodgkin Lymphoma

    著者: , , , , , , , , , , , - The Oncologist 2022 被引用: 49

  19. North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Aric C. Hall, Meagan A. Jacoby, Jeffrey E. Lancet, Gabriel N. Mannis, Anthony S. Stein, Alice S. Mims, David A. Rizzieri, Rebecca L. Olin, Alexander E. Perl, Gary J. Schiller, Paul J. Shami, Richard M. Stone, Stephen A. Strickland, Matthew J. Wieduwilt, Naval Daver, Farhad Ravandi, Sumithira Vasu, Mónica L. Guzmán, Gail J. Roboz, Joseph D. Khoury, Muzaffar H. Qazilbash, Phyu P. Aung, Branko Cuglievan, Yazan F. Madanat, Mohamed A. Kharfan‐Dabaja, Anna Pawłowska, Justin Taylor, Martin S. Tallman, Prajwal Dhakal, Andrew A. Lane - Blood 2022 被引用: 56

  20. Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes

    著者: , , , , , , , , , , , , , , , - Nature Genetics 2015 被引用: 323

  21. Tazarotene-induced Gene 2 (TIG2), a Novel Retinoid-Responsive Gene in Skin

    著者: , , , , , , , , - Journal of Investigative Dermatology 1997 被引用: 298

  22. Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma

    著者: , , , , , , , , , , , - Blood 2015 被引用: 231

  23. A Phase II trial of Belinostat ( PXD 101) in patients with relapsed or refractory peripheral or cutaneous T‐cell lymphoma

    著者: , , , , , , , , , , , , , , , , , , - British Journal of Haematology 2014 被引用: 190

  24. Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrea Combalía, Stephanie K. Fabbro, Paolo Fava, Vieri Grandi, Constanze Jonak, Estela Martínez-Escala, Meenal Kheterpal, E.J. Kim, Christopher McCormack, Tomomitsu Miyagaki, Denis Miyashiro, Stephen Morris, Cristina Muniesa, Vasiliki Nikolaou, G. Ognibene, Francesco Onida, Simona Osella‐Abate, Stefanie Porkert, Concepción Postigo‐Llorente, C. Ram‐Wolff, Simone Ribero, Kortney Rogers, Martina Sanlorenzo, René Stranzenbach, Natalie Spaccarelli, Andrew Stevens, Daniela Zugna, Alain H. Rook, Larisa J. Geskin, Rein Willemze, Sean Whittaker, Richard T. Hoppe, Julia Scarisbrick, Y. Kim - Annals of Oncology 2017 被引用: 136